Drug companies seek more clinical trial volunteers

Among the many obstacles drug companies face in bringing a product to market, recruiting clinical trial volunteers has become increasingly difficult, according to  a recent article on www.washingtonpost.com by Lenny Bernstein. Bernstein states that more than 10% of...

Electronic tools the future of biopharma’s clinical trial files

Nick Paul Taylor from fiercebiotechit.com provides a unique look at how biopharma companies are moving from paper clinical trial data to electronic files. The article talks about how many vendors are now pushing the electronic filing method for a variety of reasons...

Quintiles produces new screening checklist

Zachary Brennan from outsourcing-pharma.com just published an article on Quintiles’ Good Research for Comparative Effectiveness (GRACE) checklist. It was published in a peer–review study in March and contains 11 checkpoints for data and research methods that will help...

Mega-Trials: the new norm?

Numerous pharmaceuticals are approved and marketed based on the premise that they favorably change disease state-biomarkers. However, recent data has shown that altering the biomarkers indicative of disease does not necessarily translate to ameliorated health.  In an...